662 related articles for article (PubMed ID: 33428177)
1. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
[TBL] [Abstract][Full Text] [Related]
2. Sovateltide (IRL-1620) affects neuronal progenitors and prevents cerebral tissue damage after ischemic stroke.
Ranjan AK; Briyal S; Khandekar D; Gulati A
Can J Physiol Pharmacol; 2020 Sep; 98(9):659-666. PubMed ID: 32574518
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K; Osanai T; Uchiyama S; Minematsu K; Taguchi A; Maruichi K; Niiya Y; Asaoka K; Kuga Y; Takizawa K; Haraguchi K; Yoshimura S; Kimura K; Tokunaga K; Aoyama A; Ikawa F; Inenaga C; Abe T; Tominaga A; Takahashi S; Kudo K; Fujimura M; Sugiyama T; Ito M; Kawabori M; Hess DC; Savitz SI; Hirano T;
JAMA Neurol; 2024 Feb; 81(2):154-162. PubMed ID: 38227308
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.
Hernández-Jiménez M; Abad-Santos F; Cotgreave I; Gallego J; Jilma B; Flores A; Jovin TG; Vivancos J; Hernández-Pérez M; Molina CA; Montaner J; Casariego J; Dalsgaard M; Liebeskind DS; Cobo E; Castellanos M; Portela PC; Masjuán J; Moniche F; Tembl JI; Terceño Izaga M; Arenillas JF; Callejas P; Olivot JM; Calviere L; Henon H; Mazighi M; Piñeiro D; Pugliese M; González VM; Moro MA; Garcia-Tornel A; Lizasoain I; Ribo M
JAMA Neurol; 2023 Aug; 80(8):779-788. PubMed ID: 37338893
[TBL] [Abstract][Full Text] [Related]
7. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
[TBL] [Abstract][Full Text] [Related]
8. Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Chao AC; Lee TH; Pettigrew LC; Hannawi Y; Huang HY; Chi NF; Chan L; Chen PL; Devlin T
Drug Des Devel Ther; 2024; 18():2033-2042. PubMed ID: 38859883
[TBL] [Abstract][Full Text] [Related]
9. Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial.
Hu MZ; Zhou ZY; Zhou ZY; Lu H; Gao M; Liu LM; Song HQ; Lin AJ; Wu QM; Zhou HF; Li L; Wang X; Cai YF
Chin J Integr Med; 2020 Jun; 26(6):420-427. PubMed ID: 32361934
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
Wang A; Jia B; Zhang X; Huo X; Chen J; Gui L; Cai Y; Guo Z; Han Y; Peng Z; Jing P; Chen Y; Liu Y; Yang Y; Wang F; Sun Z; Li T; Sun H; Yuan H; Shao H; Gao L; Zhang P; Wang F; Cao X; Shi W; Li C; Yang J; Zhang H; Wang F; Deng J; Liu Y; Deng W; Song C; Chen H; He L; Zhao H; Li X; Yang H; Zhou Z; Wang Y; Miao Z;
JAMA Neurol; 2023 Aug; 80(8):851-859. PubMed ID: 37358859
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
Elkins J; Veltkamp R; Montaner J; Johnston SC; Singhal AB; Becker K; Lansberg MG; Tang W; Chang I; Muralidharan K; Gheuens S; Mehta L; Elkind MSV
Lancet Neurol; 2017 Mar; 16(3):217-226. PubMed ID: 28229893
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled trial.
Ni J; Chen H; Chen G; Ji Y; Yi F; Zhang Z; Yang Y; Wu J; Cai X; Shao B; Wang J; Liu Y; Geng D; Qu X; Li X; Wei Y; Ding J; Lü H; Huang Y; Huang Y; Xiao B; Gong T; Cui L;
BMC Neurol; 2020 Jul; 20(1):282. PubMed ID: 32664877
[TBL] [Abstract][Full Text] [Related]
13. Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study.
Chabriat H; Bassetti CL; Marx U; Picarel-Blanchot F; Sors A; Gruget C; Saba B; Wattez M; Audoli ML; Hermann DM
Trials; 2020 Feb; 21(1):136. PubMed ID: 32014032
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial.
Li B; Wang Y; Lu J; Liu J; Yuan Y; Yu Y; Wang P; Zhao X; Wang Z
Trials; 2015 Dec; 16():561. PubMed ID: 26654631
[TBL] [Abstract][Full Text] [Related]
15. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial.
Zhang Q; Wang A; Xu Q; Xia X; Tian X; Zhang Y; Li X; Yang X; Wang X; Peng J; Li Y; Liu L; Jin S; Meng X; Zhao X;
JAMA Netw Open; 2023 Aug; 6(8):e2328828. PubMed ID: 37578791
[TBL] [Abstract][Full Text] [Related]
19. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy.
Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N
Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536
[TBL] [Abstract][Full Text] [Related]
20. Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke (ADVENT): Study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Guo ZN; Zhang KJ; Zhang P; Qu Y; Abuduxukuer R; Nguyen TN; Chen HS; Yang Y
Eur Stroke J; 2024 Jun; 9(2):510-514. PubMed ID: 38196129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
